Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Common Stock Repurchased

Cash spent buying back the company's own shares.

Organigram Global Inc.NASDAQ: OGI

Common Stock Repurchased · Q2 FY2026 · quarter ended Mar 2026

Common stock repurchased outflow grows to CA$0

Q2 FY2026 common stock repurchased was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month common stock repurchased was CA$0.

Context

  • Common stock repurchased amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Common stock repurchased increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly common stock repurchased holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearSep 2025
CA$0— YoY
LTMMar 2026
CA$0— YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

CAD · from the cash flow

Latest · FY2025
0 CAD
Year-over-year change
—

Common Stock Repurchased vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
  • Common stock repurchased amounts to 0.0% of revenue for OGI, versus a peer median of 0.0%.
OGI Competitors
Common Stock Repurchased for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INFUInfuSystem Holdings, Inc.LTM Mar 2026$8.83M USD+85.6%+18.2%6.2%
ELMDElectromed, Inc.LTM Mar 2026$7.59M USD+2.4%+90.4%10.6%
HSDTSolana CompanyLTM Mar 2026$3.52M USD——36.8%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$428K USD——1.3%
OGIOrganigram Global Inc.LTM Mar 2026CA$0 CAD——0.0%
ACBAurora Cannabis Inc.LTM Mar 2026CA$0 CAD——0.0%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$0 USD——0.0%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$0 USD——0.0%
IVAInventiva S.A.FY2025€0 EUR——0.0%
DERMJourney Medical CorporationLTM Mar 2026$0 USD——0.0%
Peer median (excluding OGI) —+44.0%+54.3%0.0%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.08M12.08M17.98M
Deferred Income Tax42.21M(88K)(2.66M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(4.06M)27.02M13.16M
Other Non-Cash Items776K(29M)151.8M15.09M14.16M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(4.3M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(12.22M)
Acquisitions (Net)(2.54M)(11.06M)00(65.62M)
Purchases of Investments(120.02M)(15M)(7.36M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M36.37M3.52M2.5M
Other Investing Activities(31.08M)4.29M31.46M(8.32M)21.8M
Investing Cash Flow(115.11M)44.03M4.56M(38.77M)(59.35M)
Debt Repayment(116.4M)(1.01M)(64.04K)(786K)(43.08K)
Common Stock Issued284.88M6.34M20K108.56M29.57M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(754.15K)6K(1.29M)
Financing Cash Flow174.46M5.33M(754.15K)107.78M28.24M
Effect of Forex Changes0000(2.57M)
Net Change in Cash30.77M13.15M(68.52M)72.88M(37.98M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(16.52M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.